We are excited to announce our second publication of the year.The study titled “Spatial-hindrance-based pro-Adalimumab prevents…
We are pleased to share that our latest research article,“Development of a tumor-region-selective activation monoclonal antibody…
With profound sadness and utmost respect, we announce the passing of Chair Professor Tien-Lu Cheng, Co-Founder…
PrecisemAb Biotech drew strong attention at the BIO International Convention held in San Diego, showcasing its…
PrecisemAb Biotech is pleased to announce a technology licensing collaboration with GlycoNex to develop next-generation anti-glycan…
This award recognizes our outstanding performance as a startup company and also shows our great market…
Ministry of Science and Technology (MOST) has led 14 start-up teams specializing in new drug development,…
Professor Tien-Lu Cheng, Director of Research & Development at Kaohsiung Medical University and a veteran antibody…
Congratulations on PrecisemAb’s winning of 2021 Zhan-Guo-Ce National Startup Competition championship in business incubation group. Zhan-Guo-Ce National…
Congratulations on PrecisemAb’s winning of 2019 Outstanding Entrepreneurship Award from FITI Program hosted by Ministry of Science and…
Professor Tien-Lu Cheng, Director of Research and Development at Kaohsiung Medical University (KMU), has led his…